Humana Inc.’s HUM subsidiaries, Conviva Care Center and CenterWell Senior Primary Care, recently collaborated with the leading training provider for military cultural awareness, PsychArmor. The two subsidiaries form HUM’s Primary Care Organization. The tie-up provides the healthcare providers and employees at 23 senior primary care centers of HUM in Texas access to the Veteran Ready Healthcare Certificate program. Conviva Care Centers located in San Antonio, El Paso and Corpus Christi, along with CenterWell Senior Primary Care Centers in Houston and the Rio Grande Valley, are currently participating in the program. The training program is designed to get an in-depth understanding of military culture and veteran-specific issues, providing insight into the unique health needs of aging veterans and their families. A certification process remains in place for training healthcare providers and support staff to detect common obstacles veterans face in accessing high-quality healthcare. The courses cover topics such as military culture, effective communication with veterans, suicide prevention, opioid use disorder and more. A better understanding implies well-informed healthcare professionals, who remain equipped to foster more genuine connections with patients and extend enhanced assistance to ensure proper care. On establishing strong relationships with primary care providers and care teams, patients are more likely to keep appointments, follow treatment plans and openly share their health concerns. Therefore, improved health outcomes remain an inevitable result for the targeted population. Therefore, such tie-ups may serve as a means to retain existing customers as well as attract new ones, thereby boosting medical membership growth for Humana. A growing customer base drives the premiums of a health insurer. The recent move also reflects Humana’s sincere efforts to sustain its longstanding record of effectively serving veterans, service members and their families through various initiatives. Examples include the veteran-focused Humana USAA Honor plans for Medicare Advantage beneficiaries, administration of the TRICARE health program in collaboration with the Department of Defense and extensive partnerships with Veterans Service Organizations. The company also operates a dedicated veterans call center, promotes diverse hiring initiatives and offers health literacy programs for veterans. This time, PsychArmor seems to be the apt partner for complementing HUM’s endeavor since its team consists of clinical psychologists and social workers with deep military cultural experience who create continuing education and customized training programs. Meanwhile, Humana’s efforts to cater to the veteran community seem to be time opportune considering a greying U.S. population. There are 8.3 million veterans aged 65 and older in the United States, often with unique health needs. To better serve this medically vulnerable community, CenterWell Senior Primary Care, alongside its sister brand Conviva Care Center, remains in place. The two brands together provided care to approximately 318,000 seniors across nearly 300 centers in 15 states as of Mar 31, 2024. Shares of Humana have gained 4.1% in the past three months against the industry’s 4.1% fall. Zacks Investment Research Image Source: Zacks Investment Research HUM currently has a Zacks Rank #4 (Sell). Stocks to Consider Some better-ranked stocks in the Medical space are Tenet Healthcare Corporation THC, Encompass Health Corporation EHC and Elevance Health, Inc. ELV. While Tenet Healthcare sports a Zacks Rank #1 (Strong Buy), Encompass Health and Elevance Health carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Tenet Healthcare’s earnings surpassed estimates in each of the last four quarters, the average surprise being 56.50%. The Zacks Consensus Estimate for THC’s 2024 earnings indicates a rise of 22.5% from the year-earlier actual. The consensus mark for THC’s earnings has moved 4.5% north in the past 30 days. The bottom line of Encompass Health outpaced estimates in each of the trailing four quarters, the average surprise being 18.74%. The Zacks Consensus Estimate for EHC’s 2024 earnings indicates a rise of 12.6% while the same for revenues implies an improvement of 10.5% from the respective year-earlier actuals. The consensus mark for EHC’s earnings has moved 1% north in the past 60 days. Elevance Health’s earnings surpassed estimates in each of the last four quarters, the average surprise being 2.77%. The Zacks Consensus Estimate for ELV’s 2024 earnings indicates a rise of 12.4% while the consensus mark for revenues implies an improvement of 1% from the respective year-earlier actuals. The company has witnessed two upward estimate revisions compared with no downward revisions over the past 30 days for 2024 earnings. Shares of Tenet Healthcare, Encompass Health and Elevance Health have gained 28.9%, 2.4% and 3.3%, respectively, in the past three months. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Humana Inc. (HUM):Free Stock Analysis Report Tenet Healthcare Corporation (THC):Free Stock Analysis Report Encompass Health Corporation (EHC):Free Stock Analysis Report Elevance Health, Inc. (ELV):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Humana (HUM) Ties Up With PsychArmor for Better Veteran Care
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...